India's Aesthetic Clinics Anticipate Growth Amid Stricter Botox Regulations
Organised aesthetic clinics set to gain from tighter rules on Botox
Image: Business Standard
India's aesthetic injectables market, valued at approximately ₹700 crore (around $81.9 million), is set for transformation as the Central Drugs Standard Control Organisation (CDSCO) imposes stricter regulations on Botox and fillers. This shift is expected to drive consumers towards organized clinics, enhancing safety and compliance while curbing unregulated providers.
- 01The aesthetic injectables market in India is projected to grow to approximately $205.5 million by 2033, with a CAGR of over 12%.
- 02The CDSCO's clarification mandates that injectables are classified as medical products, not cosmetics, increasing scrutiny on unregulated providers.
- 03Organized clinics are expected to benefit as consumers prioritize safety and qualified practitioners over low-cost, unregulated services.
- 04The clarification is anticipated to enhance compliance across the supply chain, affecting importers and distributors of aesthetic products.
- 05Despite tighter regulations, demand for aesthetic procedures remains high, particularly among younger consumers seeking preventive treatments.
Advertisement
In-Article Ad
India's aesthetic injectables market, currently valued at around ₹700 crore (approximately $81.9 million), is poised for significant changes following new regulations from the Central Drugs Standard Control Organisation (CDSCO). The CDSCO has clarified that injectables like Botox and hyaluronic acid fillers must be treated as medical products, not cosmetics, leading to increased regulatory scrutiny. This shift is expected to formalize the aesthetics market, which has seen a surge in demand driven by social media influence and rising disposable incomes. Industry experts predict that organized dermatology clinics will benefit as consumers increasingly seek safety and qualified practitioners over unregulated services. The market is projected to grow at a CAGR of over 12%, reaching about $205.5 million by 2033. However, the enforcement of these regulations may pose challenges, particularly in monitoring the vast number of unregulated clinics across India. Despite potential disruptions, the demand for injectable procedures is expected to remain strong, especially among younger consumers opting for aesthetic treatments.
Advertisement
In-Article Ad
The stricter regulations are likely to enhance consumer safety and trust in aesthetic procedures, leading to a shift towards organized clinics.
Advertisement
In-Article Ad
Reader Poll
How do you feel about the new regulations on aesthetic injectables?
Connecting to poll...
Read the original article
Visit the source for the complete story.